Miyano Ryotaro, Shiraishi Tomohiro
Department of Plastic and Reconstructive Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.
Department of Plastic and Reconstructive Surgery, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka, Tokyo, Japan.
Breast Cancer. 2025 Sep 25. doi: 10.1007/s12282-025-01784-6.
Prepectoral implant placement has become a widely adopted alternative to subpectoral reconstruction in implant-based breast surgery, offering reduced postoperative pain and improved aesthetic outcomes. However, in Japan, prepectoral placement of silicone breast implants (SBIs) remains unapproved, and its clinical safety has not been well established.
We conducted a retrospective review of 176 patients (187 breasts) who underwent immediate two-stage breast reconstruction with tissue expander (TE) placement between January 2023 and December 2024. Patients were categorized into prepectoral (128 patients, 135 breasts) and subpectoral (48 patients, 52 breasts) groups. Postoperative complications including infection, seroma, and TE exposure were compared. Univariate and multivariate logistic regression analyses were performed to identify risk factors.
Infection occurring without skin or NAC necrosis was more frequent in the prepectoral group (13.3% vs. 2.2%, p = 0.03), with 14 of 17 cases requiring invasive treatment and 10 leading to TE removal or unplanned autologous reconstruction. Seroma occurred in 15.6% of prepectoral cases versus 1.9% of subpectoral (p = 0.01), and TE exposure occurred only in the prepectoral group (4.6%). Multivariate analysis identified prepectoral placement and a final fill ratio < 0.6 as independent predictors of infection. Prepectoral placement was also the sole predictor for seroma.
Prepectoral TE placement in Japanese patients was associated with a higher risk of infection, seroma, and TE exposure compared to subpectoral placement. These findings suggest the need for careful patient selection and surgical planning in the context of Japanese clinical practice, where prepectoral SBI use is not yet established.
在基于植入物的乳房手术中,胸肌前植入物放置已成为胸肌下重建广泛采用的替代方法,具有减轻术后疼痛和改善美学效果的优点。然而,在日本,硅胶乳房植入物(SBI)的胸肌前放置仍未获批,其临床安全性尚未得到充分证实。
我们对2023年1月至2024年12月期间接受组织扩张器(TE)即时两阶段乳房重建的176例患者(187侧乳房)进行了回顾性研究。患者分为胸肌前组(128例患者,135侧乳房)和胸肌下组(48例患者,52侧乳房)。比较术后感染、血清肿和TE外露等并发症。进行单因素和多因素逻辑回归分析以确定危险因素。
胸肌前组无皮肤或乳头乳晕复合体(NAC)坏死的感染更为常见(13.3%对2.2%,p = 0.03),17例中有14例需要侵入性治疗,10例导致TE移除或计划外自体重建。血清肿在胸肌前组发生率为15.6%,而胸肌下组为1.9%(p = 0.01),TE外露仅发生在胸肌前组(4.6%)。多因素分析确定胸肌前放置和最终填充率<0.6是感染的独立预测因素。胸肌前放置也是血清肿的唯一预测因素。
与胸肌下放置相比,日本患者胸肌前TE放置感染、血清肿和TE外露风险更高。这些发现表明,在日本临床实践中,由于胸肌前SBI使用尚未确立,需要仔细选择患者和进行手术规划。